Literature DB >> 8636005

Expression of CD44 variant exons 8-10 in gastric cancer.

A Yamaguchi1, M Saito, T Gio, A Iida, K Takeuchi, K Hirose, G Nakagawara, T Urano, K Furukawa, H Shiku.   

Abstract

The expression of CD44 variant containing variant exons 8-10 product (CD44v8-10) was studied by western blot analysis and immunohistochemistry in gastric cancers using a monoclonal antibody, 44-1V. On western blots, a single band of 130 kD was recognized in stomach cancer cell lines. CD44v8-10 expression, with reactivity localized in the cell membrane, was found in 65 (33.5%) of the 194 advanced gastric cancers. There was no correlation between CD44v8-10 immunoreactivity and serosal, lymphatic, or lymph node invasion. However, there was significant correlation with CD44v8-10 immunoreactivity and venous invasion. CD44v8-10-positive cancers were more frequently associated with hematogenous metastasis than those which were immunonegative. There was an inverse association between CD44v8-10 immunoreactivity and peritoneal dissemination, especially in diffuse type adenocarcinomas. These observations indicate that CD44v8-10 may play a role in the metastasis of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8636005      PMCID: PMC5920665          DOI: 10.1111/j.1349-7006.1995.tb03310.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  19 in total

1.  A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man.

Authors:  S T Jalkanen; R F Bargatze; L R Herron; E C Butcher
Journal:  Eur J Immunol       Date:  1986-10       Impact factor: 5.532

2.  Isolation and DNA sequence of a cDNA clone encoding a lymphocyte adhesion receptor for high endothelium.

Authors:  R L Idzerda; W G Carter; C Nottenburg; E A Wayner; W M Gallatin; T St John
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior.

Authors:  W Rudy; M Hofmann; R Schwartz-Albiez; M Zöller; K H Heider; H Ponta; P Herrlich
Journal:  Cancer Res       Date:  1993-03-15       Impact factor: 12.701

4.  Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1.

Authors:  J Lesley; R Schulte; R Hyman
Journal:  Exp Cell Res       Date:  1990-04       Impact factor: 3.905

5.  Expression of CD44R1 adhesion molecule in colon carcinomas and metastases.

Authors:  K K Tanabe; L M Ellis; H Saya
Journal:  Lancet       Date:  1993-03-20       Impact factor: 79.321

6.  Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

Authors:  G R Screaton; M V Bell; D G Jackson; F B Cornelis; U Gerth; J I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

7.  Prevention of tumor metastasis formation by anti-variant CD44.

Authors:  S Seiter; R Arch; S Reber; D Komitowski; M Hofmann; H Ponta; P Herrlich; S Matzku; M Zöller
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

8.  Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.

Authors:  K Miyake; C B Underhill; J Lesley; P W Kincade
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

9.  A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.

Authors:  K H Heider; M Hofmann; E Hors; F van den Berg; H Ponta; P Herrlich; S T Pals
Journal:  J Cell Biol       Date:  1993-01       Impact factor: 10.539

10.  Distinct effects of two CD44 isoforms on tumor growth in vivo.

Authors:  M S Sy; Y J Guo; I Stamenkovic
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  9 in total

Review 1.  The normal structure and function of CD44 and its role in neoplasia.

Authors:  R J Sneath; D C Mangham
Journal:  Mol Pathol       Date:  1998-08

Review 2.  CD44 and the adhesion of neoplastic cells.

Authors:  Z Rudzki; S Jothy
Journal:  Mol Pathol       Date:  1997-04

3.  CD44 family proteins in gastric cancer: a meta-analysis and narrative review.

Authors:  Ying Wu; Zhi Li; Chenlu Zhang; Kai Yu; Zan Teng; Guoliang Zheng; Shuang Wang; Yunpeng Liu; Lei Cui; Xiaosong Yu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  Rapid and reliable detection of CD44 variants in gastric carcinoma using a nested reverse transcription-polymerase chain reaction.

Authors:  Yan Wang; Yuhong Liu; Bai Xiao
Journal:  Oncol Lett       Date:  2015-09-02       Impact factor: 2.967

5.  Comparable roles of CD44v8-10 and CD44s in the development of bone metastases in a mouse model.

Authors:  Toru Hiraga; Hiroaki Nakamura
Journal:  Oncol Lett       Date:  2016-08-10       Impact factor: 2.967

6.  Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.

Authors:  Jie Yang
Journal:  Med Oncol       Date:  2020-03-27       Impact factor: 3.064

7.  Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer.

Authors:  Kohei Otsubo; Kaname Nosaki; Chiyo K Imamura; Hiroaki Ogata; Akitaka Fujita; Shinya Sakata; Fumihiko Hirai; Gouji Toyokawa; Eiji Iwama; Taishi Harada; Takashi Seto; Mitsuhiro Takenoyama; Takeshi Ozeki; Taisei Mushiroda; Mieko Inada; Junji Kishimoto; Kenji Tsuchihashi; Kentaro Suina; Osamu Nagano; Hideyuki Saya; Yoichi Nakanishi; Isamu Okamoto
Journal:  Cancer Sci       Date:  2017-07-26       Impact factor: 6.716

8.  Circulating tumor cells expressing cancer stem cell marker CD44 as a diagnostic biomarker in patients with gastric cancer.

Authors:  Toru Watanabe; Tomoyuki Okumura; Katsuhisa Hirano; Tetsuji Yamaguchi; Shinichi Sekine; Takuya Nagata; Kazuhiro Tsukada
Journal:  Oncol Lett       Date:  2016-11-24       Impact factor: 2.967

Review 9.  Potential of Stem Cells and CART as a Potential Polytherapy for Small Cell Lung Cancer.

Authors:  Evgenii Skurikhin; Olga Pershina; Mariia Zhukova; Darius Widera; Natalia Ermakova; Edgar Pan; Angelina Pakhomova; Sergey Morozov; Aslan Kubatiev; Alexander Dygai
Journal:  Front Cell Dev Biol       Date:  2021-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.